• SAHBANATHUL MISSRIYA MA Department of Nursing, College of Applied Medical Sciences, King Faisal University, Alahsa, Kingdom of Saudi Arabia.
  • SUHAIL HASSAN Department of Pharmacy, Jaya College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Thiruvallur, Chennai, Tamil Nadu, India.


Objective: Coronavirus disease is the first pandemic caused by a novel coronavirus. The World Health Organization announced a name for the novel coronavirus disease 2019 (COVID-19). This epidemic must stop, contain, control, delay, and reduce the impact of this virus by the people at every opportunity. Every person has the responsibility to contribute, to protect themselves, to protect others, whether in the home, the community, the health-care system, the workplace, or in the transport system. The study was aimed to assess the level of awareness and attitude regarding the prevention of novel coronavirus disease among people and to associate the knowledge level about the prevention of novel coronavirus disease with selected demographic variables of people.

Methods: A cross-sectional descriptive design was adopted. Using a convenient sampling technique, 950 samples were selected. The data were collected, analyzed in terms of both descriptive, and inferential statistics.

Results: The study results showed that among the total number of people (950) surveyed, 499 (52.6%) were having poor knowledge, whereas 348 (36.6%) were having an average level of knowledge and 103 (10.8%) were showing good knowledge regarding prevention of COVID-19. Some of the people (40.7%) had a negative attitude on the overall aspects of COVID-19 prevention.

Conclusion: The study concluded that there were inadequate awareness and poor attitude among the people about coronavirus diseases, and hence there is a need to create awareness through campaigns by public authorities and media.

Keywords: Assess, Coronavirus disease 2019, Awareness, Attitude, Prevention


1. Hsue B, Hartshorne T, Masters PS. Characterization of an essential RNA secondary structure in the 3’ untranslated region of the murine coronavirus genome. J Virol 2000;74:6911-21.
2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727-33.
3. Macjkenzie JS, Smith DW. COVID-19: A novel zoonotic disease caused by a coronavirus from China: What we know and what we don’t. Microbiol Aust 2020;41:45-50.
4. Chen Y, Cai H, Pan J, Xiang N, Tien P, Ahola T, et al. Functional Screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. Proc Natl Acad Sci U S A 2009;106:3484-9.
5. Kar SK, Arafat SM, Sharma P, Dixit A, Marthoenis M, Kabir R. COVID-19 pandemic and addiction: Current problems and future concerns. Asian J Psychiatr 2020;51:102064.
6. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239-42.
7. Chan JF, Yuan S, Kok K, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020;395:514-23.
8. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020;382:970-1.
9. Yu P, Zhu J, Zhang Z, Han Y, Huang L. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. J Infect Dis 2020;221:jiaa077.
10. Ebrahim SH, Memish ZA. COVID-19: Preparing for superspreader potential among Umrah Pilgrims to Saudi Arabia. Lancet 2020;395:e48.
11. Achonu C, Laporte A, Gardam MA. The financial impact of controlling a respiratory virus outbreak in a teaching hospital: Lessons learned from SARS. Can J Public Health 2005;96:52-4.
12. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, et al. COVID-19: Towards controlling of a pandemic. Lancet 2020;395:1015-8.
13. Algaissi A, Alharbi N, Hassanain M, Hashem A. Preparedness and Response to COVID-19 in Saudi Arabia: Lessons Learned from MERS-CoV. Basel: Preprints; 2020.
14. Sudan P, Goswami M, Babu MA. Novel coronavirus (COVID-19)-a critical review. Int J Res Pharm Sci 2020;11:43-7.
15. Gaunt ER, Hardie A, Claas EC, Simmonds P, Templeton KE.Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 2010;48:40-7.
16. Parameshwar K, Pamu S, Sandeep K, Suresh C. A review novel coronavirus. Asian J Pharm Clin Res 2020;13:12-7.
17. Brende B, Farrar J, Gashumba D, Moedas C, Mundel T, Shiozaki Y, et al. CEPI-A new global R&D organisation for epidemic preparedness and response. Lancet 2017;389:233-5.
18. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020;395:470-3.
19. Shah NM, Rahim MA. Parental knowledge, attitudes and practices (KAPS) on the use of antibiotics in children for upper respiratory tract infections (URTIS). Int J Pharm Pharm Sci 2017;9:105-10.
20. Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients: A systemic review and meta-analysis. Research (Wash D C) 2020;2020:2402961.
21. Zhong BL, Luo W, Li HM, Zhang QQ, Liu XG, Li WT, et al. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: A quick online cross-sectional survey. Int J Biol Sci 2020;16:1745-52.
22. Zhang X, Sun Y, Ye D, Sun Z, Su H, Ni J, et al. Analysis on mental health status of community residents in Hefei during SARS spread. Chin J Dis Contr Prev 2003;7:280-2.
23. Jiao J, Tang X, Li H, Chen J, Xiao Y, Li A, et al. Survey of knowledge of villagers in prevention and control of SARS in Hainan Province. Chin Trop Med 2005;5:703-5.
24. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020;382:1177-9.
25. Kim JY, Ko JH, Kim Y, Kim YJ, Kim JM, Chuna YS. Viral load kinetics of SARS-CoV-2 infection in first two patients in Korea. J Korean Med Sci 2020;35:e86.
26. Smith JA, Judd J. COVID-19: Vulnerability and the power of privilege in a pandemic. Health Promot J Aust 2020;31:158-60.
27. Akunne MO, Chukwueke UC, Anosie C. Assessment of knowledge of Zika virus infection among health care professionals in a Southeastern State of Nigeria. Int J Pharm Pharm Sci 2018;10:56-60.
28. Sauriasari R, Apriyanti YF, Pramono D. Assessment of antibiotic prescription in patients with non-pneumonia acute respiratory tract infection. Int J Appl Pharm 2018;10:66-9.
57 Views | 57 Downloads
How to Cite
MA, S. M., and S. HASSAN. “ASSESS THE AWARENESS AND ATTITUDE REGARDING PREVENTION OF CORONAVIRUS DISEASE 2019”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 7, Apr. 2020, pp. 95-98, doi:10.22159/ajpcr.2020.v13i7.37804.
Original Article(s)